BORGESON BLAKE sold 0.5% of their position (30K shares) of RECURSION PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $105.6K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 5/7/2026ACC: 0001856094-26-000005
Director
Since Apr 2021
-30K
Net shares
Net seller
$105.6K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
30K disposed
Non-Derivative Transactions1
Class A Common Stock
Direct
Shares
−30K
Price / share
$3.52
Trade value
$105.60K
% of position
0.5%
5/5/2026
6.23M→6.20M
Total
Net shares
−30K
Net value
-$105.60K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 5/5/2026 | S · Sale | −30K | $3.52 | $105.60K | 0.5% | 6.23M | 6.20M |
| Total | −30K | -$105.60K | ||||||
Derivative Transactions0
No derivative transactions reported